PAX3-FOXO1-induced transcriptional dysregulation in rhabdomyosarcoma

被引：0
|
作者：
Stevens, Bradley T.
Zhang, Yang
Adkins, Grace E.
Hopkins, Jack D.
Kimbrough, Darden W.
Garcia, Matthew R.
Hatley, Mark E.
Abraham, Brian J.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PEDIATRIC24-A001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A001
引用
收藏
页数：3
相关论文
共 50 条
  • [31] IRIZIO: a novel gene cooperating with PAX3-FOXO1 in alveolar rhabdomyosarcoma (ARMS)
    Picchione, Fabrizio
    Pritchard, Colin
    Lagutina, Irina
    Janke, Laura
    Grosveld, Gerard C.
    CARCINOGENESIS, 2011, 32 (04) : 452 - 461
  • [32] P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma
    Bharathy, Narendra
    Suriyamurthy, Sudha
    Rao, Vinay Kumar
    Ow, Jin Rong
    Lim, Huey Jin
    Chakraborty, Payal
    Vasudevan, Madavan
    Dhamne, Chetan Anil
    Chang, Kenneth Tou En
    Min, Victor Lee Kwan
    Kundu, Tapas K.
    Taneja, Reshma
    JOURNAL OF PATHOLOGY, 2016, 240 (03): : 269 - 281
  • [33] PAX3-FOXO1 a target genes in alveolar rhabdomyosarcoma: Possible therapeutic targets
    Marshall, Amy D.
    van der Ent, Martijn A.
    Grosveld, Gerard C.
    CANCER RESEARCH, 2010, 70
  • [34] In vivo recombination of two BAC clones to recreate the transcriptional landscape of the Pax3:FoxO1 fusion gene in Alveolar Rhabdomyosarcoma
    Balcells, Barbara Villarejo
    Rigby, Peter W. J.
    Carvajal, Jaime J.
    MECHANISMS OF DEVELOPMENT, 2009, 126 : S226 - S226
  • [35] Novel histone lysine demethylase inhibitors disrupt PAX3-FOXO1-driven transcriptional output in fusion-positive rhabdomyosarcoma
    Kim, Yong Yean
    Woldemichael, Girma
    Gryder, Berkley
    Pomella, Silvia
    Sinniah, Ranuka
    Kowalczyk, Josh
    Song, Young
    Churiwal, Mehal
    Barchi, Joseph
    Schneekloth, John
    Wen, Xinyu
    Chou, Hsein-Chao
    Okeefe, Barry
    Shern, John
    Hawley, Robert
    Khan, Javed
    CANCER RESEARCH, 2022, 82 (12)
  • [36] The PAX3-FOXO1 Fusion Protein Present in Rhabdomyosarcoma Interferes with Normal FOXO Activity and the TGF-β Pathway
    Schmitt-Ney, Michel
    Camussi, Giovanni
    PLOS ONE, 2015, 10 (03):
  • [37] Investigation of PAX3-FOXO1 Effect on NEAT1 Expression in Alveolar Rhabdomyosarcoma Cells
    George, Victoria Agbeke
    McDaniel, Brianyell
    Johanson, Kelly E.
    FASEB JOURNAL, 2017, 31
  • [38] Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma
    Singh, Shivendra
    Abu-Zaid, Ahmed
    Jin, Hongjian
    Fang, Jie
    Wu, Qiong
    Wang, Tingting
    Feng, Helin
    Quarni, Waise
    Shao, Ying
    Maxham, Lily
    Abdolvahabi, Alireza
    Yun, Mi-Kyung
    Vaithiyalingam, Sivaraja
    Tan, Haiyan
    Bowling, John
    Honnell, Victoria
    Young, Brandon
    Guo, Yian
    Bajpai, Richa
    Pruett-Miller, Shondra M.
    Grosveld, Gerard C.
    Hatley, Mark
    Xu, Beisi
    Fan, Yiping
    Wu, Gang
    Chen, Eleanor Y.
    Chen, Taosheng
    Lewis, Peter W.
    Rankovic, Zoran
    Li, Yimei
    Murphy, Andrew J.
    Easton, John
    Peng, Junmin
    Chen, Xiang
    Wang, Ruoning
    White, Stephen W.
    Davidoff, Andrew M.
    Yang, Jun
    SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (653)
  • [39] Transcriptional co-activators TAZ/YAP are novel regulators of PAX3-FOXO1 transcriptional programing and fusion-positive rhabdomyosarcoma cancer cell stemness
    Burgess, Breanne A.
    Slemmons, Katherine K.
    Linardic, Corinne M.
    Deel, Michael D.
    CANCER RESEARCH, 2019, 79 (13)
  • [40] PAX3/FOXO1 fusion gene status reveals rhabdomyosarcoma risk stratification
    Miller, Sarah
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (05) : 553 - 553
12345